Progyny, Inc.
PGNY
NASDAQ·Healthcare·Medical - Healthcare Plans·Mkt cap $2.0B
$25.94
▼ -2.52%
P/E
27.31
Mkt Cap
$2.0B
52-Wk Range
$16.10–$33.07
52-Week Range
$16.10 - $33.07
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 13.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized expertise in fertility and family building benefits with differentiated plan design
- Integrated concierge-style member support services creating high engagement and retention
- Selective network of vetted fertility specialists ensuring quality care and cost management
- Comprehensive integrated platform combining medical, pharmacy, and family building benefits
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing employer demand for fertility benefits as talent acquisition and retention tool
Value
Fairly valued vs Healthcare IT & Services peers
Momentum
Stable
+0.1% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying PGNY right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 6, 2026
Reported EPS of $0.36 vs $0.33 consensus (+7.5% surprise). Revenue of $350.5M vs $349.0M expected (+0.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+7.5%
Revenue trend · last 8Q
—
+11%
+17%
+9%
+9%
+7%
+1%
+5%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$286.6M
$298.4M
$324.0M
$332.9M
$313.3M
$318.4M
$328.5M
$350.5M
Margins · last 8Q
Gross
25.5%
Operating
11.4%
Profit
8.0%
Wall Street consensus
7 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Citi · Sep 2, 2026
vs Industry
How PGNY stacks vs Medical - Healthcare Plans
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related